The FDA has clarified that built-in technical age verification is not a universal prerequisite for the marketing authorization of flavored e-cigarettes. Manufacturers may provide other evidence to demonstrate that their product protects public health.
The U.S. Food and Drug Administration (FDA) has clarified that the presence of built-in digital age verification is not mandatory for the marketing authorization of flavored e-cigarettes. Bret Koplow, Director of the FDA’s Center for Tobacco Products (CTP), explained the agency’s position in response to an inquiry from Glas Inc. The question arose after R.J. Reynolds launched flavored Vuse Pro pods that are compatible with Vuse Alto batteries, which lack built-in age restrictions.
In May, Glas received authorization for four pods—including mango and blueberry flavors—which use smartphone-based authentication to exclude underage users. However, according to the FDA’s draft guidance from March, device-level access restriction is only one of many risk-mitigation tools and is not considered a general requirement when evaluating flavored products.
Manufacturers must continue to demonstrate that marketing their products is appropriate for the protection of public health, weighing the benefits provided to adult smokers against the risks to young people. Technological authentication may help facilitate application approval, but companies can also substantiate compliance using other evidence.
In Brief
- The FDA does not consider built-in age-verification technology a general prerequisite for the approval of flavored vaping systems.
- The clarification was requested by the manufacturer Glas after R.J. Reynolds introduced flavored Vuse Pro pods without such technology.
- Restrictive technology is only one of several potential tools for reducing youth-related risks during the premarket review process.
- Manufacturers must still prove that marketing the product protects public health overall.
Source: Vaping360 (vaping360.com)
This summary was created by artificial intelligence based on the original article.